PMC:7461420 / 30173-30621
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T162 | 4-29 | Body_part | denotes | neurotransmitter receptor | http://purl.org/sig/ont/fma/fma67184 |
T163 | 189-196 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T164 | 236-244 | Body_part | denotes | clathrin | http://purl.org/sig/ont/fma/fma62262 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T169 | 150-154 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T170 | 326-337 | Disease | denotes | hepatitis C | http://purl.obolibrary.org/obo/MONDO_0005231 |
T171 | 326-335 | Disease | denotes | hepatitis | http://purl.obolibrary.org/obo/MONDO_0002251 |
T172 | 345-355 | Disease | denotes | infectious | http://purl.obolibrary.org/obo/MONDO_0005550 |
T173 | 356-366 | Disease | denotes | bronchitis | http://purl.obolibrary.org/obo/MONDO_0003781 |
T174 | 391-400 | Disease | denotes | hepatitis | http://purl.obolibrary.org/obo/MONDO_0002251 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T338 | 234-235 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T339 | 310-315 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T340 | 338-343 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T341 | 367-372 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T342 | 385-390 | http://purl.obolibrary.org/obo/CLO_0007836 | denotes | mouse |
T343 | 401-406 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T263 | 4-20 | Chemical | denotes | neurotransmitter | http://purl.obolibrary.org/obo/CHEBI_25512 |
T264 | 39-53 | Chemical | denotes | chlorpromazine | http://purl.obolibrary.org/obo/CHEBI_3647 |
T265 | 60-72 | Chemical | denotes | promethazine | http://purl.obolibrary.org/obo/CHEBI_8461 |
T266 | 83-95 | Chemical | denotes | fluphenazine | http://purl.obolibrary.org/obo/CHEBI_5123 |
T267 | 189-196 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T268 | 218-232 | Chemical | denotes | Chlorpromazine | http://purl.obolibrary.org/obo/CHEBI_3647 |
T269 | 266-275 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T14 | 326-335 | Phenotype | denotes | hepatitis | http://purl.obolibrary.org/obo/HP_0012115 |
T15 | 356-366 | Phenotype | denotes | bronchitis | http://purl.obolibrary.org/obo/HP_0012387 |
T16 | 391-400 | Phenotype | denotes | hepatitis | http://purl.obolibrary.org/obo/HP_0012115 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
960 | 137-145 | Species | denotes | MERS‐CoV | Tax:1335626 |
961 | 150-158 | Species | denotes | SARS‐CoV | Tax:694009 |
962 | 310-315 | Species | denotes | human | Tax:9606 |
963 | 316-319 | Species | denotes | CoV | Tax:11118 |
964 | 326-343 | Species | denotes | hepatitis C virus | Tax:11103 |
965 | 345-372 | Species | denotes | infectious bronchitis virus | Tax:11120 |
966 | 385-406 | Species | denotes | mouse hepatitis virus | Tax:11138 |
967 | 320-324 | Species | denotes | 229E | Tax:11137 |
968 | 39-53 | Chemical | denotes | chlorpromazine | MESH:D002746 |
969 | 60-72 | Chemical | denotes | promethazine | MESH:D011398 |
970 | 83-95 | Chemical | denotes | fluphenazine | MESH:D005476 |
971 | 218-232 | Chemical | denotes | Chlorpromazine | MESH:D002746 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T283 | 0-212 | Sentence | denotes | The neurotransmitter receptor blockers chlorpromazine (15), promethazine (16), and fluphenazine (17; Figure 7), were reported to inhibit MERS‐CoV and SARS‐CoV‐1 most probably by impeding S protein‐induced fusion. |
T284 | 213-416 | Sentence | denotes | 103 Chlorpromazine, a clathrin‐mediated viral entry inhibitor, was already described to inhibit human CoV‐229E, hepatitis C virus, infectious bronchitis virus, as well as mouse hepatitis virus‐2 (MHV2). |
T285 | 417-448 | Sentence | denotes | 104 , 105 , 106 , 107 , 108 |